Oncology News | Medical Oncologists - ESMO
WEBThe latest daily oncology news for medical oncologists from the European Society for Medical Oncology.
European Society for Medical Oncology
WEBESMO is a professional organisation for medical oncologists in Europe and beyond. It offers education, research, advocacy and events, including the ESMO Congress 2024 in Barcelona or online.
Latest News - ESMO Daily Reporter
WEBStay up-to-date with the latest advances in cancer care by reading our news on studies presented at ESMO congresses and other hot topics in oncology.
ESMO Daily Reporter
WEBLiquid biopsy plays a growing role in early-stage lung cancer. Research is moving forward to understand the value of this blood-based technology as a prognostic tool. 14 Sept 2024. The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society.
Gynaecological Cancers: Immunotherapy and Novel Targeted Drug
WEBSep 14, 2024 · Lugano, Switzerland – Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial (1) and cervical cancers (2) who gain clinically meaningful benefit from adding immunotherapy to current standard treatments, while a first-in-human study found ‘promising’ antitumour activity with a novel antibody drug conjugate (ADC) targeting the protein claudin 6 in heavily ...
2023 MASCC and ESMO guideline update for the prevention of
WEBJan 11, 2024 · The European Society for Medical Oncology (ESMO) and the Multinational Association of Supportive Care in Cancer (MASCC) completed the fourth Consensus Conference on Antiemetics for the prevention of nausea and vomiting in patients with cancer in Copenhagen in June 2015. …
Studies show immunotherapy improves long-term | EurekAlert!
WEBNews Release 15-Sep-2024. Studies show immunotherapy improves long-term survival in growing number of cancers. Reports and Proceedings. European Society for Medical Oncology. Lugano, Switzerland ...
Researchers announce clinical trial results for hard-to-treat breast ...
WEB5 days ago · Professors Tom Powles and Peter Schmid recently delivered results from their phase three clinical trials during Sunday's Presidential Symposium to over 30,000 attendees at the European Society for ...
GSK, iTeos Score Phase II Win for Jemperli-TIGIT Combo in NSCLC
WEB5 days ago · GSK and iTeos presented these data at the 2024 European Society for Medical Oncology Congress (ESMO 2024). Michel Detheux, iTeos’ president and CEO, noted in a statement that the partners are “encouraged” by these data, which points to the “potential differentiation” of combining an anti-TIGIT therapy with a PD-1 treatment.
Home Page: ESMO Open
WEBMar 6, 2024 · ESMO Real-World Data and Digital Oncology is the European Society for Medical Oncology's latest peer-reviewed open access journal. It is dedicated to publishing high-quality data science and educational content on the transformation of oncology care with real-world evidence and digital technologies that physicians can trust and understand.